Total amount: € 0,00
Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1812
Incardona V. M., Dato E., Dato A. G.
Centro di Diagnostica Cardiovascolare del Dott. Dato Achille Giuseppe & C. Sas, Paternò, Catania, Italia
The renin-angiotension system inhibition is a very efficacious pharmacological approach in control of cardiovascular and renal diseases. Aliskiren is a direct inhibitor of rennin and clinical trials prove a good control of blood pressure and protective effect in cardiovascular and renal diseases. After the promising results obtained, future clinical trials asses and confirm the organ-protective effects of aliskiren in the vascular diseases.